Biodistribution Processes as Underestimated Confounders in Translational Stroke Research

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|14|30|3179-3184

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.30, 2007-12, pp. : 3179-3184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotective and neurotrophic curcuminoids to treat stroke: a translational perspective

By Lapchak Paul A  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 1, 2011-01 ,pp. : 13-22

Informa Healthcare

Access to resources Recommend Favorite

Stroke research is severely underfunded

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 314, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke

By Greenhalgh Andrew D   Ogungbenro Kayode   Rothwell Nancy J   Galea James P  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 6, 2011-06 ,pp. : 681-695

Informa Healthcare

Access to resources Recommend Favorite

Erythropoietin molecules to treat acute ischemic stroke: a translational dilemma!

By Lapchak Paul A  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1179-1186

Informa Healthcare

Access to resources Recommend Favorite

Controversies in translational research: drug self-administration

By Haney Margaret   Spealman Roger  

Psychopharmacology, Vol. 199, Iss. 3, 2008-08 ,pp. : 403-419

Springer Publishing Company

Access to resources Recommend Favorite